Numerous studies including randomized clinical trials have highlighted the association of low baseline CD4+ T cell counts, a high viral load at the time of initiation of ART, a shorter interval between TB treatment and ART initiation, and a high mycobacterial burden with the increased risk of paradoxical TB-IRIS [14,34,36,43]. The gene discussed is CD4; the disease is tuberculosis.